Acetaminophen

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

118 Suppliers, 84 USDMF, 20 CEP/COS, 16 JDMF, 7 EU WC, 108 KDMF, 105 NDC API, 28 Listed Suppliers

DEVELOPMENTS

36 Drug(s) in Development

36 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Forms

2413 Dossiers, 727 FDA Orange Book, 482 Europe, 299 Canada, 73 Australia, 376 South Africa, 456 Listed Dossiers

DRUG PRODUCT COMPOSITION

SUPPOSITORY;RECTAL - 120MG, SUPPOSITORY;RECTAL - 325MG, SUPPOSITORY;RECTAL - 650MG, SUPPOSITORY;RECTAL - 80MG, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 250MG;250MG;65MG, TABLET;ORAL - 325MG;37.5MG, SOLUTION;INTRAVENOUS - 1GM/100ML (10MG/ML), TABLET;ORAL - 300MG;15MG, TABLET;ORAL - 300MG;30MG, TABLET;ORAL - 300MG;60MG, TABLET;ORAL - 325MG;5MG, TABLET;ORAL - 325MG;50MG;40MG, TABLET;ORAL - 300MG;60MG

RELATED EXCIPIENT COMPANIES

Suppliers, 56 Roquette, 44 BASF, 39 Kerry, 31 SPI Pharma, 27 Microlex e.U, 22 Nanjing Well Pharmaceutical, 22 Seppic, 19 Actylis, 17 Gangwal Chemicals, 16 Gangwal Healthcare, 14 Rochem International Inc, 13 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 12 Corel Pharma Chem, 12 Boai NKY Pharmaceuticals Ltd, 12 Sigachi Industries, 8 DKSH, 8 Beneo, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 DFE Pharma, 7 Ideal Cures Pvt Ltd, 6 Lonza Capsugel, 6 Clariant, 5 Kima Chemical, 5 Vasa Pharmachem, 5 Ingredion Pharma Solutions, 5 Prachin Chemical, 5 Pharmatrans-Sanaq, 4 Alcedo Pharmachem, 4 The Dow Chemical Company, 4 Ulanqab Kema New Material, 4 Finar, 4 ACG Worldwide, 3 Zhejiang Huakang Pharmaceutical, 3 Shijiazhuang Huaxu Pharmaceutical, 3 Aeon Procare, 3 Pharm-RX Chemical, 3 Jai Radhe Sales, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Qualicaps, 2 Minakem, 2 Seqens, 2 Bioplus Life Sciences, 2 Huzhou Sunflower Pharmaceutical, 2 Pfanstiehl, 1 Chynops Pharma, 1 Avesta Pharma, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Evonik, 1 Shanghai Welltone Material Technology Co., Ltd, 1 NEWEDGE Overseas

EXCIPIENTS BY APPLICATIONS

126 Fillers, Diluents & Binders, 67 Solubilizers, 67 Coating Systems & Additives, 61 Thickeners and Stabilizers, 59 Taste Masking, 56 Direct Compression, 50 Disintegrants & Superdisintegrants, 48 Topical, 44 Parenteral, 40 Controlled & Modified Release, 39 Lubricants & Glidants, 39 Granulation, 38 Film Formers & Plasticizers, 27 Chewable & Orodispersible Aids, 20 Emulsifying Agents, 20 Co-Processed Excipients, 13 API Stability Enhancers, 12 Surfactant & Foaming Agents, 9 Rheology Modifiers, 9 Empty Capsules, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

32 US Medicaid Prescriptions, 381 Finished Drug Prices

MARKET PLACE

164 APIs, 93 DOSSIERS // FDF

PATENTS

40 US Patents, 1 US Exclusivities, 3 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 BioAnalytical Methods, 8 Analytical Solutions, 1 EDQM Standards, 7 USP Standards, 1 JP Standards, 21 Other Ref. Standards

DIGITAL CONTENT

10 Data Compilation & Company Tracker #PharmaFlow, 330 News

Information, Expiry & Status of Health Canada Patents covering Acetaminophen.

Acetaminophen

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

118 Suppliers

84 USDMF

20 CEP/COS

16 JDMF

7 EU WC

108 KDMF

105 NDC API

28 Listed Suppliers

DEVELOPMENTS

36 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Forms

2413 Dossiers

727 FDA Orange Book

482 Europe

299 Canada

73 Australia

376 South Africa

456 Listed Dossiers

DRUG PRODUCT COMPOSITION

SUPPOSITORY;RECTAL - 120MG

SUPPOSITORY;RECTAL - 325MG

SUPPOSITORY;RECTAL - 650MG

SUPPOSITORY;RECTAL - 80MG

CAPSULE;ORAL - 325MG;50MG;40MG;30MG

TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 250MG;250MG;65MG

TABLET;ORAL - 325MG;37.5MG

SOLUTION;INTRAVENOUS - 1GM/100ML (10MG/ML)

TABLET;ORAL - 300MG;15MG

TABLET;ORAL - 300MG;30MG

TABLET;ORAL - 300MG;60MG

TABLET;ORAL - 325MG;5MG

TABLET;ORAL - 325MG;50MG;40MG

TABLET;ORAL - 300MG;60MG

RELATED EXCIPIENT COMPANIES

Suppliers

56 Roquette

44 BASF

39 Kerry

31 SPI Pharma

27 Microlex e.U

22 Nanjing Well Pharmaceutical

22 Seppic

19 Actylis

17 Gangwal Chemicals

16 Gangwal Healthcare

14 Rochem International Inc

13 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

12 Corel Pharma Chem

12 Boai NKY Pharmaceuticals Ltd

12 Sigachi Industries

8 DKSH

8 Beneo

8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

7 DFE Pharma

7 Ideal Cures Pvt Ltd

6 Lonza Capsugel

6 Clariant

5 Kima Chemical

5 Vasa Pharmachem

5 Ingredion Pharma Solutions

5 Prachin Chemical

5 Pharmatrans-Sanaq

4 Alcedo Pharmachem

4 The Dow Chemical Company

4 Ulanqab Kema New Material

4 Finar

4 ACG Worldwide

3 Zhejiang Huakang Pharmaceutical

TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons